Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma
Inger Z. M. Kreuger, Roderick C. Slieker, Tim van Groningen, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 1, pp. 18-25.e1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Mechanisms of cuproptosis and its relevance to distinct diseases
Qiao-mei Lou, Feifan Lai, Jingwei Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 981-1006
Closed Access | Times Cited: 10
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Kimberly J. Briggs, Kevin M. Cottrell, Matthew R. Tonini, et al.
Translational Oncology (2025) Vol. 52, pp. 102264-102264
Open Access | Times Cited: 1
Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors
Di Zhang, Tao Wang, Zhou Yi, et al.
Medicine (2023) Vol. 102, Iss. 14, pp. e33468-e33468
Open Access | Times Cited: 19
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
Tareq Saleh, Sarah Bloukh, Mira Hasan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188994-188994
Closed Access | Times Cited: 17
Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics
Kulkaew Sukniam, Harsheen Kaur Manaise, Kyle Popp, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 465-465
Open Access | Times Cited: 6
Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy
Olamide Tosin Olaoba, Temitope Isaac Adelusi, Ming Yang, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1808-1808
Open Access | Times Cited: 5
Interactions between lncRNAs and cyclins/CDKs complexes; key players in determining cancer cell response to CDKs inhibitors
Bahaa Ibrahim Saeed, Abhinav Kumar, Enwa Felix Oghenemaro, et al.
Experimental Cell Research (2025) Vol. 445, Iss. 2, pp. 114406-114406
Closed Access
Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas
Julia Pikul, Marcin M. Machnicki, Anna Rzepakowska, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Inflammasome activation in melanoma progression: the latest update concerning pathological role and therapeutic value
Nakaraj Pluetrattanabha, Thanyaporn Direksunthorn, Irfan Ahmad, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
Yong Huang, Huibin Li, Zhifu Wei, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CDKN2ALowcancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistance
Raquel Buj, Aidan R. Cole, John R. Danielson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
Pancreatic Cancer: Pathogenesis and Clinical Studies
Kexun Zhou, Yingping Liu, Chuanyun Tang, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Cell Death Modalities in Therapy of Melanoma
Meng Wang, Jiahui Zhao, Ming Tang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3475-3475
Open Access
Recent Developments in Targeting the Cell Cycle in Melanoma
Christie Hung, Trang Nguyen, Poulikos I. Poulikakos, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1291-1291
Open Access
Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma
Tianqi Luo, Zhijin Fan, Anyu Zeng, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 4
The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
Jiahua Liu, Runzi Zheng, Yanghuan Zhang, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2640-2640
Open Access | Times Cited: 10
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 5, pp. 1174-1188
Open Access | Times Cited: 3
The Construction of a Multi-Gene Risk Model for Colon Cancer Prognosis and Drug Treatments Prediction
Liyang Gao, Ye Tian, Erfei Chen
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3954-3954
Open Access | Times Cited: 2
CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma
Xiang Yong, Yanling Zhang, Heng Tang, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 2
Oxidative State in Cutaneous Melanoma Progression: A Question of Balance
Mascia Benedusi, Heaji Lee, Yunsook Lim, et al.
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1058-1058
Open Access | Times Cited: 2
Cell Senescence and the Genetics of Melanoma Development
Sophie M. Constantinou, Dorothy C. Bennett
Genes Chromosomes and Cancer (2024) Vol. 63, Iss. 10
Open Access | Times Cited: 2
Loss of p16 Immunoexpression and Deletions of CDKN2A in the Progression of Extramammary Paget Disease: An Immunohistochemical and Genetic Study of 24 Invasive/Metastatic Cases
Tsubasa Hiraki, Takuma Oishi, Shusuke Yoshikawa, et al.
American Journal of Dermatopathology (2024)
Closed Access | Times Cited: 1
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness
Matilde Monti, Luisa Benerini Gatta, Mattia Bugatti, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top